- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/539 - Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody involving precipitating reagent
Patent holdings for IPC class G01N 33/539
Total number of patents in this class: 48
10-year publication summary
|
1
|
2
|
1
|
7
|
6
|
2
|
4
|
4
|
4
|
8
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Abbott Point Of Care Inc. | 319 |
3 |
| Genzyme Corporation | 1205 |
3 |
| Washington University | 1473 |
3 |
| Cytosed, Inc. | 4 |
2 |
| University of Utah Research Foundation | 1737 |
2 |
| Wavesense, Inc. | 27 |
2 |
| Vision Diagnostics, Inc. | 9 |
2 |
| The Regents of the University of California | 18943 |
1 |
| Board of Regents, The University of Texas System | 5370 |
1 |
| The Johns Hopkins University | 5377 |
1 |
| Tsinghua University | 5426 |
1 |
| Sumitomo Rubber Industries, Ltd. | 4421 |
1 |
| The Board of Trustees of the University of Illinois | 2623 |
1 |
| Affisink Biotechnology Ltd. | 3 |
1 |
| Arizona Board of Regents on behalf of Arizona State University | 2226 |
1 |
| Beckman Coulter, Inc. | 1183 |
1 |
| Icemos Technology Ltd. | 51 |
1 |
| InDevR, Inc. | 30 |
1 |
| Korea Center for Disease Control and Prevention | 16 |
1 |
| Korea Institute of Radiological & Medical Sciences | 126 |
1 |
| Other owners | 18 |